Mizuho Securities increased its price objective on Cabot shares, and Lazard Asset Management LLC increased its stake in the company.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho Securities increased its price objective on Cabot shares, and Lazard Asset Management LLC increased its stake in the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cabot Corporation
American specialty chemicals and performance materials company
Nothing else this week.
-
Mizuho Securities
Japanese investment banking company
Nothing else this week.
-
Lazard Asset Management LLC
Capital market company
Related events
- Mizuho Securities set a price objective on the stock of Assembly Biosciences, Inc., which trades on the Nasdaq stock exchange.
- Citigroup reaffirmed a buy rating and Mizuho set a price objective for Booking Holdings on August 30, 2026.
- Mizuho Securities lifted its price target and disclosed a transaction involving Guardant Health in an SEC filing.
- Mizuho Securities cut its target price for Agree Realty on September 20, 2026.
- Morgan Stanley downgraded GE Vernova shares, while Mizuho lifted its price objective and JPMorgan Chase upped its target price.